These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23543638)

  • 1. Glucagon-like peptide-1 (GLP-1) raises blood-brain glucose transfer capacity and hexokinase activity in human brain.
    Gejl M; Lerche S; Egefjord L; Brock B; Møller N; Vang K; Rodell AB; Bibby BM; Holst JJ; Rungby J; Gjedde A
    Front Neuroenergetics; 2013; 5():2. PubMed ID: 23543638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon-like peptide-1 decreases intracerebral glucose content by activating hexokinase and changing glucose clearance during hyperglycemia.
    Gejl M; Egefjord L; Lerche S; Vang K; Bibby BM; Holst JJ; Mengel A; Møller N; Rungby J; Brock B; Gjedde A
    J Cereb Blood Flow Metab; 2012 Dec; 32(12):2146-52. PubMed ID: 22929437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon-like peptide-1 inhibits blood-brain glucose transfer in humans.
    Lerche S; Brock B; Rungby J; Bøtker HE; Møller N; Rodell A; Bibby BM; Holst JJ; Schmitz O; Gjedde A
    Diabetes; 2008 Feb; 57(2):325-31. PubMed ID: 17991759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of GLP-1 on myocardial glucose metabolism in healthy men during normo- or hypoglycemia.
    Gejl M; Lerche S; Mengel A; Møller N; Bibby BM; Smidt K; Brock B; Søndergaard H; Bøtker HE; Gjedde A; Holst JJ; Hansen SB; Rungby J
    PLoS One; 2014; 9(1):e83758. PubMed ID: 24400077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. At the centennial of Michaelis and Menten, competing Michaelis-Menten steps explain effect of GLP-1 on blood-brain transfer and metabolism of glucose.
    Gejl M; Rungby J; Brock B; Gjedde A
    Basic Clin Pharmacol Toxicol; 2014 Aug; 115(2):162-71. PubMed ID: 24684709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers.
    Nauck MA; Heimesaat MM; Behle K; Holst JJ; Nauck MS; Ritzel R; Hüfner M; Schmiegel WH
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1239-46. PubMed ID: 11889194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain glucose transport and phosphorylation under acute insulin-induced hypoglycemia in mice: an 18F-FDG PET study.
    Alf MF; Duarte JM; Schibli R; Gruetter R; Krämer SD
    J Nucl Med; 2013 Dec; 54(12):2153-60. PubMed ID: 24159048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptide 1 attenuates the acceleration of gastric emptying induced by hypoglycemia in healthy subjects.
    Plummer MP; Jones KL; Annink CE; Cousins CE; Meier JJ; Chapman MJ; Horowitz M; Deane AM
    Diabetes Care; 2014 Jun; 37(6):1509-15. PubMed ID: 24598243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blind placebo-controlled cross over study.
    Deane AM; Chapman MJ; Fraser RJ; Burgstad CM; Besanko LK; Horowitz M
    Crit Care; 2009; 13(3):R67. PubMed ID: 19439067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of glucose transport in human brain gray and white matter.
    de Graaf RA; Pan JW; Telang F; Lee JH; Brown P; Novotny EJ; Hetherington HP; Rothman DL
    J Cereb Blood Flow Metab; 2001 May; 21(5):483-92. PubMed ID: 11333358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem.
    Alvarez E; Martínez MD; Roncero I; Chowen JA; García-Cuartero B; Gispert JD; Sanz C; Vázquez P; Maldonado A; de Cáceres J; Desco M; Pozo MA; Blázquez E
    J Neurochem; 2005 Feb; 92(4):798-806. PubMed ID: 15686481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-Brain Glucose Transfer in Alzheimer's disease: Effect of GLP-1 Analog Treatment.
    Gejl M; Brock B; Egefjord L; Vang K; Rungby J; Gjedde A
    Sci Rep; 2017 Dec; 7(1):17490. PubMed ID: 29235507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients With Long-QT Syndrome Caused by Impaired
    Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
    Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.
    Bahrami J; Longuet C; Baggio LL; Li K; Drucker DJ
    Gastroenterology; 2010 Sep; 139(3):857-68. PubMed ID: 20546737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo measurements of brain glucose transport using the reversible Michaelis-Menten model and simultaneous measurements of cerebral blood flow changes during hypoglycemia.
    Choi IY; Lee SP; Kim SG; Gruetter R
    J Cereb Blood Flow Metab; 2001 Jun; 21(6):653-63. PubMed ID: 11488534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-dependent insulinotropic polypeptide augments glucagon responses to hypoglycemia in type 1 diabetes.
    Christensen M; Calanna S; Sparre-Ulrich AH; Kristensen PL; Rosenkilde MM; Faber J; Purrello F; van Hall G; Holst JJ; Vilsbøll T; Knop FK
    Diabetes; 2015 Jan; 64(1):72-8. PubMed ID: 25053587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: unraveling the role of gut hormonal and pancreatic endocrine dysfunction.
    Rabiee A; Magruder JT; Salas-Carrillo R; Carlson O; Egan JM; Askin FB; Elahi D; Andersen DK
    J Surg Res; 2011 May; 167(2):199-205. PubMed ID: 21414635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous glucagon-like peptide 1 normalizes blood glucose after major surgery in patients with type 2 diabetes.
    Meier JJ; Weyhe D; Michaely M; Senkal M; Zumtobel V; Nauck MA; Holst JJ; Schmidt WE; Gallwitz B
    Crit Care Med; 2004 Mar; 32(3):848-51. PubMed ID: 15090972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood-to-brain glucose transport, cerebral glucose metabolism, and cerebral blood flow are not increased after hypoglycemia.
    Segel SA; Fanelli CG; Dence CS; Markham J; Videen TO; Paramore DS; Powers WJ; Cryer PE
    Diabetes; 2001 Aug; 50(8):1911-7. PubMed ID: 11473055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Michaelis-Menten constraints improved cerebral glucose metabolism and regional lumped constant measurements with [18F]fluorodeoxyglucose.
    Kuwabara H; Evans AC; Gjedde A
    J Cereb Blood Flow Metab; 1990 Mar; 10(2):180-9. PubMed ID: 2303534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.